Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Personalisation of leukaemia treatment using genome sequencing
Dr Giovanni Martinelli - University of Bologna, Bologna, Italy
Personalisation of leukaemia treatment using genome sequencing ( Dr Giovanni Martinelli - University of Bologna, Bologna, Italy )
5 May 2014
Phase I trial shows the benefits of OTX015 in treating blood cancer
Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland
Phase I trial shows the benefits of OTX015 in treating blood cancer ( Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland )
1 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014
AG-221 shows clinical activity in acute myeloid leukaemia
Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA
AG-221 shows clinical activity in acute myeloid leukaemia ( Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2014
Effective use of ibrutinib in the treatment of ABC lymphoma tumours
Dr Louis Staudt - National Cancer Institute, Bethesda, USA
Effective use of ibrutinib in the treatment of ABC lymphoma tumours ( Dr Louis Staudt - National Cancer Institute, Bethesda, USA )
1 May 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Reasons for combining immunotherapy with chemo to enhance anti tumour response
Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated...
Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology ( Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands )
25 Mar 2014
Molecular pathways associated with immune modulation and thalidomide analogues
Dr Rajesh Chopra - Vice President of Translational and Early Drug Development...
Molecular pathways associated with immune modulation and thalidomide analogues ( Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene )
25 Mar 2014
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios...
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014
Critical insights on leukaemia and lymphoma from ASH 2013
Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014
Rituximab maintenance therapy and CLL treatment considerations going forward
Prof Ulrich Jäger - Medical University of Vienna, Austria
Rituximab maintenance therapy and CLL treatment considerations going forward ( Prof Ulrich Jäger - Medical University of Vienna, Austria )
1 Jan 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation